(Q56430406)

3

object named as

Ilonka Kreitschmann-Andermahr

0 references

author name string

Harald Jörn Schneider

1

0 references

Gianluca Aimaretti

2

0 references

Günter-Karl Stalla

4

0 references

Ezio Ghigo

5

0 references

language of work or name

English

0 references

publication date

April 2007

0 references

28 April 2007

0 references

published in

The Lancet

0 references

volume

369

0 references

issue

9571

0 references

page(s)

1461-1470

0 references

cites work

Pituitary insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Ueber Hypophysisschwund mit tödlichem Ausgang1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Anterior pituitary dysfunction in survivors of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Occurrence of pituitary dysfunction following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Hypopituitarism following severe traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Fatigue after aneurysmal subarachnoid hemorrhage evaluated by pituitary function and 3D-CBF.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Epidemiological aspects of spontaneous subarachnoid haemorrhage in Queensland, Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

A systematic review of brain injury epidemiology in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Anterior pituitary hormone abnormalities following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Consensus guidelines on screening for hypopituitarism following traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Medical management of hypopituitarism in patients with pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

1 reference

7 January 2021

Hypothalamic lesions following the rupture of cerebral berry aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Hypothalamic lesions following closed head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Traumatic infarction of the anterior lobe of the pituitary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

A Survival Case of Myxedema Coma of Pituitary Origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Disorders of water balance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Low- and standard-dose corticotropin and insulin hypoglycemia testing in the assessment of hypothalamic-pituitary-adrenal function after pituitary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Diagnosis of growth-hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Consensus statement on the management of the GH-treated adolescent in the transition to adult care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

New approach to the diagnosis of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Discrepant results in the diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients with traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Diagnosis of adult GH deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Posterior pituitary dysfunction after traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Hydrocortisone dose and postoperative diabetes insipidus in patients undergoing transsphenoidal pituitary surgery: a prospective randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Expert meeting: hypopituitarism after traumatic brain injury and subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Surgical treatment of craniopharyngiomas: endocrinological results.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Diagnosis and treatment of hypopituitarism: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Increased need for thyroxine in women with hypothyroidism during estrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Estrogen replacement in women of fertile years with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Postmenopausal hormone replacement therapy and venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

1 reference

7 January 2021

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Induction of Ovulation and Spermatogenesis by hMG/hCG in Hypogonadotropic GH-Deficient Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

1 reference

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Breast cancer and hormone-replacement therapy: the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Testosterone replacement therapy: current trends and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Cognitive changes during growth hormone replacement in adult men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021

Central effects of the somatotropic system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960673-4

7 January 2021